avril 2022

Vyant Bio

Vyant Bio

Sole Agent (ATM Offering)

Canaccord Genuity Acted as Sole Agent to Vyant Bio on its $20 Million At-the-Market Offering

More Like This

novembre 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
octobre 2024

Telemos Capital

Exclusive Financial Advisor (Buy side)
US$46m

octobre 2024

TELA Bio

Joint Bookrunner (Follow-On Offering)

Afficher les transactions Healthcare